Purchases through the above links give commission which helps fund this website
Recent literature: Bone resorption inhibitor
Date Journal Article title
2019 May J Endocr Soc The Bone Phenotype and Pain Response to Pamidronate in Tyrosine Kinase Inhibitor-Treated Chronic Myelogenous Leukemia.
2019 Apr JCI Insight Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.
2019 Apr Expert Opin Pharmacother Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss.
2019 Bone Rep Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib presses osteoclastic bone resorption.
2019 J Bone Oncol Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model.
2019 Biomed Res Int Positive Correlation between Activated CypACD147 Signaling and MMP-9 Expression in Mice Inflammatory Periapical Lesion.
2019 Jpn Dent Sci Rev Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.
2019 Mar Basic Clin Pharmacol Toxicol Lansoprazole inhibits the cysteine protease legumain by binding to the active site.
2019 Mar Bone Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
2019 Mar FASEB J Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP presses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
2019 Mar J Periodontal Res Angiopoietin-like 4 production upon treatment with hypoxia and L-mimosine in periodontal fibroblasts.
2019 May Exp Cell Res Fusion and hemagglutinin proteins of canine distemper virus promote osteoclast formation through NF-κB dependent and independent mechanisms.
2018 Dec Cureus Malignant Sarcomatous Transformation of Benign Giant Cell Tumor of Bone after Treatment with Denosumab Therapy: A Literature Review of Reported Cases.
2019 Mar Bone Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormone.
2019 Mol Med Rep NEMO‑binding domain peptide ameliorates inflammatory bone destruction in a Staphylococcus aureus‑induced chronic osteomyelitis model.
2019 Clin Calcium [Regulations of osteoclast formation and function by Wnt signals.]
2019 Feb J Tissue Eng Regen Med Nanoparticulate mineralized collagen glycosaminoglycan materials directly and indirectly inhibit osteoclastogenesis and osteoclast activation.
2019 Feb Arthritis Rheumatol Activation of the PGC-1βNFATc-1 Pathway in Circulating Osteoclast Precursors Associated with Bone Destruction in Rheumatoid Arthritis.
2019 Bone Sostdc1: A soluble BMP and Wnt antagonist that is induced by the interaction between myeloma cells and osteoblast lineage cells.
2019 Feb Nutrients Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity.
2019 Mar Free Radic Res Glutathione accelerates osteoclast differentiation and inflammatory bone destruction.
2019 Feb Osteoporos Int Association of blood n-3 fatty acid with bone mass and bone marrow TRAP-5b in the elderly with and without hip fracture.
2019 Mar Biochem Biophys Res Commun Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes.
2019 Tohoku J Exp Med Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
2019 Feb J Bone Miner Metab Novel bisphosphonate compound FYB-931 preferentially inhibits aortic calcification in vitamin D3-treated rats.
2019 FASEB J Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
2019 Mar Biochem Biophys Res Commun Role of ANTXR1 in the regulation of RANKL-induced osteoclast differentiation and function.
2019 Apr Eur J Pharmacol Histone deacetylase inhibitor CI-994 inhibits osteoclastogenesis via pressing NF-κB and the downstream c-FosNFATc1 signaling pathways.
2019 Drug Dev Ind Pharm Bioactive injectable triple acting thermosensitive hydrogel enriched with nano-hydroxyapatite for bone regeneration: in-vitro characterization, Saos-2 cell line cell viability and osteogenic markers evaluation.
2019 Jan Metabolism Extracellular vesicles from human umbilical cord blood ameliorate bone loss in senile osteoporotic mice.
2019 Jan Br J Clin Pharmacol Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.
2019 J Cell Physiol AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
2019 Feb J Med Chem Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.
2018 J Dent Anesth Pain Med Propofol promotes osteoclastic bone resorption by increasing DC-STAMP expression.
2019 J Clin Periodontol Inhibition of Ctsk alleviates periodontitis and comorbid rheumatoid arthritis via downregulation of the TLR9 signalling pathway.
2019 Jan Biomolecules Specialized Roles for Actin in Osteoclasts: Unanswered Questions and Therapeutic Opportunities.
2019 Bone Res Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis.
2019 Feb Biochem J Identification of strate-specific inhibitors of cathepsin K through high-throughput screening.
2019 Jan J Bone Miner Res The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen-Dependent Bone Loss in Mice.
2019 PLoS One Calcium mimics the chemotactic effect of conditioned media and is an effective inducer of bone regeneration.
2019 Jan J Bone Miner Res Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial.
2019 Int Immunopharmacol Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators.
2019 J Pharm Pharmacol The antinociceptive effect of resveratrol in bone cancer pain is inhibited by the Silent Information Regulator 1 inhibitor selisistat.
2019 Maturitas New therapeutic targets for osteoporosis.
2019 Bone Acute hypercalcemia and excessive bone resorption following anti-RANKL withdrawal: Case report and brief literature review.
2018 Dec Int J Mol Sci Butyrate Stimulates Histone H3 Acetylation, 8-Isoprostane Production, RANKL Expression, and Regulated Osteoprotegerin ExpressionSecretion in MG-63 Osteoblastic Cells.
2019 FASEB J Prostate transmembrane protein androgen induced 1 is induced by activation of osteoclasts and regulates bone resorption.
2018 Theranostics V-ATPases and osteoclasts: ambiguous future of V-ATPases inhibitors in osteoporosis.
2019 J Bone Miner Res Roles for HB-EGF in Mesenchymal Stromal Cell Proliferation and Differentiation During Skeletal Growth.
2019 J Cell Physiol Mandibular osteotomy-induced hypoxia enhances osteoclast activation and acid secretion by increasing glycolysis.
2019 Feb Cancer Lett Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis.
2019 Jan Physiol Rev The Activity of Peptides of the Calcitonin Family in Bone.
2018 Curr Pharm Biotechnol Suppressive Effects of the Standardized Extract of Phyllanthus amarus on Type II Collagen-induced Rheumatoid Arthritis in Sprague Dawley Rats.
2019 Bone Deletion of OPN in BSP knockout mice does not correct bone hypomineralization but results in high bone turnover.
2019 Calcif Tissue Int Hyperglycemia Induces Osteoclastogenesis and Bone Destruction Through the Activation of Ca2+Calmodulin-Dependent Protein Kinase II.
2018 Nov Molecules Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-iNi-1H-Indol-5-Ylacetamide) on Osteoclast Differentiation via Suppressing Cathepsin K Expression.
2018 Nov J Neurosurg ACE-inhibitors: a preventive measure for bone flap resorption after autologous cranioplasty?
2019 J Cell Mol Med Small molecule nAS-E targeting cAMP response element binding protein (CREB) and CREB-binding protein interaction inhibits breast cancer bone metastasis.
2018 Front Pharmacol Targeting Anion Exchange of Osteoclast, a New Strategy for Preventing Wear Particles Induced- Osteolysis.
2019 Mol Cell Biochem Sirtuin 1 inhibits TNF-α-mediated osteoclastogenesis of bone marrow-derived macrophages through both ROS generation and TRPV1 activation.
2019 Mol Med Rep Streptolysin O derived from Streptococcus pyogenes inhibits RANKL‑induced osteoclastogenesis through the NF‑κB signaling pathway.
2019 J Cell Physiol Interleukin-37 inhibits osteoclastogenesis and alleviates inflammatory bone destruction.
2018 Int Immunopharmacol The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis.
2019 Biomed Pharmacother DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo.
2018 Nov J Periodontol A novel Bruton's tyrosine kinase inhibitor acalabrutinib presses osteoclast differentiation and P. gingivalis lipopolysaccharide-induced alveolar bone resorption.
2018 Ther Adv Musculoskelet Dis New and emerging concepts in the use of denosumab for the treatment of osteoporosis.
2018 Oct Int J Mol Sci The Bromodomain Inhibitor iNi-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes.
2018 Front Bioeng Biotechnol iIn vitroi Models of Bone Remodelling and Associated Disorders.
2019 J Bone Miner Metab Regulatory mechanisms of sclerostin expression during bone remodeling.
2018 Oct Pharmaceutics Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies.
2018 Front Cell Dev Biol Thy-1 Deficiency Augments Bone Loss in Obesity by Affecting Bone Formation and Resorption.
2018 Front Immunol Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.
2018 Metabolism Overexpression of Sirt1 in mesenchymal stem cells protects against bone loss in mice by FOXO3a deacetylation and oxidative stress inhibition.
2019 J Periodontal Res A novel IkB kinase inhibitor attenuates ligature-induced periodontal disease in mice.
2018 Oct Nat Commun Bone protection by inhibition of microRNA-182.